Global Antibody Fragments Market Insights and Forecast to 2026
- BMR3911172
- 112 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Antibody Fragments was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Antibody Fragments is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Antibody Fragments market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibody Fragments market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Antibody Fragments industry.
Global Antibody Fragments Scope and Segment
Antibody Fragments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Fragments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Novartis
F. Hoffmann-La Roche
Johnson & Johnson
Amgen
Bristol-Myers Squibb
AbbVie
Takeda Pharmaceutical
Sanofi
Biogen
Eli Lilly
Antibody Fragments Breakdown Data by Type
F(ab) Fragment
F(ab’)2 Fragment
Antibody Fragments Breakdown Data by Application
Cancer
Immunodeficiencies
Other
Regional and Country-level Analysis
The Antibody Fragments market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibody Fragments market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Antibody Fragments Market Share Analysis
1.1 Antibody Fragments Product Introduction
1.2 Market Segments
1.3 Key Antibody Fragments Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antibody Fragments Market Size Growth Rate by Type
1.4.2 F(ab) Fragment
1.4.3 F(ab’)2 Fragment
1.5 Market by Application
1.5.1 Global Antibody Fragments Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Immunodeficiencies
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody Fragments Market Size, Estimates and Forecasts
2.1.1 Global Antibody Fragments Revenue 2015-2026
2.1.2 Global Antibody Fragments Sales 2015-2026
2.2 Global Antibody Fragments, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antibody Fragments Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antibody Fragments Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibody Fragments Competitor Landscape by Players
3.1 Antibody Fragments Sales by Manufacturers
3.1.1 Antibody Fragments Sales by Manufacturers (2015-2020)
3.1.2 Antibody Fragments Sales Market Share by Manufacturers (2015-2020)
3.2 Antibody Fragments Revenue by Manufacturers
3.2.1 Antibody Fragments Revenue by Manufacturers (2015-2020)
3.2.2 Antibody Fragments Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antibody Fragments Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antibody Fragments Revenue in 2019
3.2.5 Global Antibody Fragments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antibody Fragments Price by Manufacturers
3.4 Antibody Fragments Manufacturing Base Distribution, Product Types
3.4.1 Antibody Fragments Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Fragments Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Fragments Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antibody Fragments Market Size by Type (2015-2020)
4.1.1 Global Antibody Fragments Sales by Type (2015-2020)
4.1.2 Global Antibody Fragments Revenue by Type (2015-2020)
4.1.3 Antibody Fragments Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antibody Fragments Market Size Forecast by Type (2021-2026)
4.2.1 Global Antibody Fragments Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody Fragments Revenue Forecast by Type (2021-2026)
4.2.3 Antibody Fragments Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antibody Fragments Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antibody Fragments Market Size by Application (2015-2020)
5.1.1 Global Antibody Fragments Sales by Application (2015-2020)
5.1.2 Global Antibody Fragments Revenue by Application (2015-2020)
5.1.3 Antibody Fragments Price by Application (2015-2020)
5.2 Antibody Fragments Market Size Forecast by Application (2021-2026)
5.2.1 Global Antibody Fragments Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody Fragments Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody Fragments Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antibody Fragments by Country
6.1.1 North America Antibody Fragments Sales by Country
6.1.2 North America Antibody Fragments Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antibody Fragments Market Facts & Figures by Type
6.3 North America Antibody Fragments Market Facts & Figures by Application
7 Europe
7.1 Europe Antibody Fragments by Country
7.1.1 Europe Antibody Fragments Sales by Country
7.1.2 Europe Antibody Fragments Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Fragments Market Facts & Figures by Type
7.3 Europe Antibody Fragments Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antibody Fragments by Region
8.1.1 Asia Pacific Antibody Fragments Sales by Region
8.1.2 Asia Pacific Antibody Fragments Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antibody Fragments Market Facts & Figures by Type
8.3 Asia Pacific Antibody Fragments Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antibody Fragments by Country
9.1.1 Latin America Antibody Fragments Sales by Country
9.1.2 Latin America Antibody Fragments Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antibody Fragments Market Facts & Figures by Type
9.3 Central & South America Antibody Fragments Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibody Fragments by Country
10.1.1 Middle East and Africa Antibody Fragments Sales by Country
10.1.2 Middle East and Africa Antibody Fragments Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antibody Fragments Market Facts & Figures by Type
10.3 Middle East and Africa Antibody Fragments Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Fragments Products Offered
11.1.5 Novartis Related Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Corporation Information
11.2.2 F. Hoffmann-La Roche Description and Business Overview
11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 F. Hoffmann-La Roche Antibody Fragments Products Offered
11.2.5 F. Hoffmann-La Roche Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Antibody Fragments Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Amgen
11.4.1 Amgen Corporation Information
11.4.2 Amgen Description and Business Overview
11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Antibody Fragments Products Offered
11.4.5 Amgen Related Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Description and Business Overview
11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Antibody Fragments Products Offered
11.5.5 Bristol-Myers Squibb Related Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Description and Business Overview
11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AbbVie Antibody Fragments Products Offered
11.6.5 AbbVie Related Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Description and Business Overview
11.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceutical Antibody Fragments Products Offered
11.7.5 Takeda Pharmaceutical Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Antibody Fragments Products Offered
11.8.5 Sanofi Related Developments
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description and Business Overview
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Antibody Fragments Products Offered
11.9.5 Biogen Related Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Corporation Information
11.10.2 Eli Lilly Description and Business Overview
11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly Antibody Fragments Products Offered
11.10.5 Eli Lilly Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Antibody Fragments Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antibody Fragments Market Estimates and Projections by Region
12.1.1 Global Antibody Fragments Sales Forecast by Regions 2021-2026
12.1.2 Global Antibody Fragments Revenue Forecast by Regions 2021-2026
12.2 North America Antibody Fragments Market Size Forecast (2021-2026)
12.2.1 North America: Antibody Fragments Sales Forecast (2021-2026)
12.2.2 North America: Antibody Fragments Revenue Forecast (2021-2026)
12.2.3 North America: Antibody Fragments Market Size Forecast by Country (2021-2026)
12.3 Europe Antibody Fragments Market Size Forecast (2021-2026)
12.3.1 Europe: Antibody Fragments Sales Forecast (2021-2026)
12.3.2 Europe: Antibody Fragments Revenue Forecast (2021-2026)
12.3.3 Europe: Antibody Fragments Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antibody Fragments Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antibody Fragments Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antibody Fragments Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antibody Fragments Market Size Forecast by Region (2021-2026)
12.5 Latin America Antibody Fragments Market Size Forecast (2021-2026)
12.5.1 Latin America: Antibody Fragments Sales Forecast (2021-2026)
12.5.2 Latin America: Antibody Fragments Revenue Forecast (2021-2026)
12.5.3 Latin America: Antibody Fragments Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antibody Fragments Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antibody Fragments Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antibody Fragments Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antibody Fragments Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antibody Fragments Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Fragments Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antibody Fragments Market Segments
Table 2. Ranking of Global Top Antibody Fragments Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antibody Fragments Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of F(ab) Fragment
Table 5. Major Manufacturers of F(ab’)2 Fragment
Table 6. Global Antibody Fragments Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Antibody Fragments Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Antibody Fragments Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Antibody Fragments Sales Market Share by Regions (2015-2020)
Table 10. Global Antibody Fragments Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antibody Fragments Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Antibody Fragments Sales Share by Manufacturers (2015-2020)
Table 13. Global Antibody Fragments Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antibody Fragments by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Fragments as of 2019)
Table 15. Antibody Fragments Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antibody Fragments Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antibody Fragments Price (2015-2020) (USD/Pcs)
Table 18. Antibody Fragments Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antibody Fragments Product Type
Table 20. Date of International Manufacturers Enter into Antibody Fragments Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 23. Global Antibody Fragments Sales Share by Type (2015-2020)
Table 24. Global Antibody Fragments Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antibody Fragments Revenue Share by Type (2015-2020)
Table 26. Antibody Fragments Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 28. Global Antibody Fragments Sales Share by Application (2015-2020)
Table 29. North America Antibody Fragments Sales by Country (2015-2020) (K Pcs)
Table 30. North America Antibody Fragments Sales Market Share by Country (2015-2020)
Table 31. North America Antibody Fragments Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antibody Fragments Revenue Market Share by Country (2015-2020)
Table 33. North America Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 34. North America Antibody Fragments Sales Market Share by Type (2015-2020)
Table 35. North America Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 36. North America Antibody Fragments Sales Market Share by Application (2015-2020)
Table 37. Europe Antibody Fragments Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Antibody Fragments Sales Market Share by Country (2015-2020)
Table 39. Europe Antibody Fragments Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antibody Fragments Revenue Market Share by Country (2015-2020)
Table 41. Europe Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Antibody Fragments Sales Market Share by Type (2015-2020)
Table 43. Europe Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Antibody Fragments Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antibody Fragments Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Antibody Fragments Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antibody Fragments Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antibody Fragments Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Antibody Fragments Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Antibody Fragments Sales Market Share by Application (2015-2020)
Table 53. Latin America Antibody Fragments Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Antibody Fragments Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antibody Fragments Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antibody Fragments Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Antibody Fragments Sales Market Share by Type (2015-2020)
Table 59. Latin America Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Antibody Fragments Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antibody Fragments Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Antibody Fragments Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antibody Fragments Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antibody Fragments Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antibody Fragments Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Antibody Fragments Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antibody Fragments Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Antibody Fragments Sales Market Share by Application (2015-2020)
Table 69. Novartis Corporation Information
Table 70. Novartis Description and Major Businesses
Table 71. Novartis Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Novartis Product
Table 73. Novartis Recent Development
Table 74. F. Hoffmann-La Roche Corporation Information
Table 75. F. Hoffmann-La Roche Description and Major Businesses
Table 76. F. Hoffmann-La Roche Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. F. Hoffmann-La Roche Product
Table 78. F. Hoffmann-La Roche Recent Development
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Description and Major Businesses
Table 81. Johnson & Johnson Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Recent Development
Table 84. Amgen Corporation Information
Table 85. Amgen Description and Major Businesses
Table 86. Amgen Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Amgen Product
Table 88. Amgen Recent Development
Table 89. Bristol-Myers Squibb Corporation Information
Table 90. Bristol-Myers Squibb Description and Major Businesses
Table 91. Bristol-Myers Squibb Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Bristol-Myers Squibb Product
Table 93. Bristol-Myers Squibb Recent Development
Table 94. AbbVie Corporation Information
Table 95. AbbVie Description and Major Businesses
Table 96. AbbVie Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. AbbVie Product
Table 98. AbbVie Recent Development
Table 99. Takeda Pharmaceutical Corporation Information
Table 100. Takeda Pharmaceutical Description and Major Businesses
Table 101. Takeda Pharmaceutical Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Takeda Pharmaceutical Product
Table 103. Takeda Pharmaceutical Recent Development
Table 104. Sanofi Corporation Information
Table 105. Sanofi Description and Major Businesses
Table 106. Sanofi Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Sanofi Product
Table 108. Sanofi Recent Development
Table 109. Biogen Corporation Information
Table 110. Biogen Description and Major Businesses
Table 111. Biogen Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Biogen Product
Table 113. Biogen Recent Development
Table 114. Eli Lilly Corporation Information
Table 115. Eli Lilly Description and Major Businesses
Table 116. Eli Lilly Antibody Fragments Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Eli Lilly Product
Table 118. Eli Lilly Recent Development
Table 119. Global Antibody Fragments Sales Forecast by Regions (2021-2026) (K Pcs)
Table 120. Global Antibody Fragments Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Antibody Fragments Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Antibody Fragments Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Antibody Fragments Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. North America: Antibody Fragments Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Antibody Fragments Sales Forecast by Country (2021-2026) (K Pcs)
Table 126. Europe: Antibody Fragments Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Antibody Fragments Sales Forecast by Region (2021-2026) (K Pcs)
Table 128. Asia Pacific: Antibody Fragments Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Antibody Fragments Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Latin America: Antibody Fragments Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Antibody Fragments Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. Middle East and Africa: Antibody Fragments Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Antibody Fragments Players
Table 137. Antibody Fragments Customers List
Table 138. Antibody Fragments Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Fragments Product Picture
Figure 2. Global Antibody Fragments Sales Market Share by Type in 2020 & 2026
Figure 3. F(ab) Fragment Product Picture
Figure 4. F(ab’)2 Fragment Product Picture
Figure 5. Global Antibody Fragments Sales Market Share by Application in 2020 & 2026
Figure 6. Cancer
Figure 7. Immunodeficiencies
Figure 8. Other
Figure 9. Antibody Fragments Report Years Considered
Figure 10. Global Antibody Fragments Market Size 2015-2026 (US$ Million)
Figure 11. Global Antibody Fragments Sales 2015-2026 (K Pcs)
Figure 12. Global Antibody Fragments Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Antibody Fragments Sales Market Share by Region (2015-2020)
Figure 14. Global Antibody Fragments Sales Market Share by Region in 2019
Figure 15. Global Antibody Fragments Revenue Market Share by Region (2015-2020)
Figure 16. Global Antibody Fragments Revenue Market Share by Region in 2019
Figure 17. Global Antibody Fragments Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Antibody Fragments Revenue in 2019
Figure 19. Antibody Fragments Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Antibody Fragments Sales Market Share by Type (2015-2020)
Figure 21. Global Antibody Fragments Sales Market Share by Type in 2019
Figure 22. Global Antibody Fragments Revenue Market Share by Type (2015-2020)
Figure 23. Global Antibody Fragments Revenue Market Share by Type in 2019
Figure 24. Global Antibody Fragments Market Share by Price Range (2015-2020)
Figure 25. Global Antibody Fragments Sales Market Share by Application (2015-2020)
Figure 26. Global Antibody Fragments Sales Market Share by Application in 2019
Figure 27. Global Antibody Fragments Revenue Market Share by Application (2015-2020)
Figure 28. Global Antibody Fragments Revenue Market Share by Application in 2019
Figure 29. North America Antibody Fragments Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Antibody Fragments Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Antibody Fragments Sales Market Share by Country in 2019
Figure 32. North America Antibody Fragments Revenue Market Share by Country in 2019
Figure 33. U.S. Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Antibody Fragments Market Share by Type in 2019
Figure 38. North America Antibody Fragments Market Share by Application in 2019
Figure 39. Europe Antibody Fragments Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Antibody Fragments Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Antibody Fragments Sales Market Share by Country in 2019
Figure 42. Europe Antibody Fragments Revenue Market Share by Country in 2019
Figure 43. Germany Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Antibody Fragments Market Share by Type in 2019
Figure 54. Europe Antibody Fragments Market Share by Application in 2019
Figure 55. Asia Pacific Antibody Fragments Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Antibody Fragments Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Antibody Fragments Sales Market Share by Region in 2019
Figure 58. Asia Pacific Antibody Fragments Revenue Market Share by Region in 2019
Figure 59. China Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Antibody Fragments Market Share by Type in 2019
Figure 82. Asia Pacific Antibody Fragments Market Share by Application in 2019
Figure 83. Latin America Antibody Fragments Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Antibody Fragments Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Antibody Fragments Sales Market Share by Country in 2019
Figure 86. Latin America Antibody Fragments Revenue Market Share by Country in 2019
Figure 87. Mexico Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Antibody Fragments Market Share by Type in 2019
Figure 94. Latin America Antibody Fragments Market Share by Application in 2019
Figure 95. Middle East and Africa Antibody Fragments Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Antibody Fragments Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Antibody Fragments Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Antibody Fragments Revenue Market Share by Country in 2019
Figure 99. Turkey Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Antibody Fragments Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Antibody Fragments Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Antibody Fragments Market Share by Type in 2019
Figure 106. Middle East and Africa Antibody Fragments Market Share by Application in 2019
Figure 107. North America Antibody Fragments Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Antibody Fragments Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Antibody Fragments Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Antibody Fragments Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Antibody Fragments Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Antibody Fragments Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Antibody Fragments Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Antibody Fragments Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Antibody Fragments Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Antibody Fragments Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
